Is Refractory Epilepsy Due to Genetically Determined Resistance to Antiepileptic Drugs?
- 10 April 2003
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (15) , 1480-1482
- https://doi.org/10.1056/nejme030023
Abstract
Failure to respond to antiseizure drugs is the usual basis for defining intractable epilepsy, although there is a lack of consensus about what constitutes drug resistance and when this determination can be made.1,2 At least 30 percent of patients with epilepsy in North America and western Europe continue to have seizures despite drug treatment.3 The figure may be even higher in adults with localization-related epilepsy.4 This situation has not changed despite the introduction of a number of antiseizure drugs in the past decade. Refractory epilepsy is associated with memory loss, lower levels of school performance, depression, impaired psychosocial skills, . . .Keywords
This publication has 19 references indexed in Scilit:
- How long does it take for partial epilepsy to become intractable?Neurology, 2003
- Regional Expression of Multidrug Resistance Genes in Genetically Epilepsy‐prone Rat Brain after a Single Audiogenic SeizureEpilepsia, 2002
- Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsyBrain, 2002
- Factors predicting prognosis of epilepsy after presentation with seizuresAnnals of Neurology, 2000
- A Family of Drug Transporters: the Multidrug Resistance-Associated ProteinsJNCI Journal of the National Cancer Institute, 2000
- “The Scarlet E”Neurology, 2000
- Pharmacoresistance in EpilepsyCNS Drugs, 1998
- MDR1 Gene Expression in Brain of Patients with Medically Intractable EpilepsyEpilepsia, 1995
- Some Aspects of Prognosis in the Epilepsies: A ReviewEpilepsia, 1993
- Comparison of Carbamazepine, Phenobarbital, Phenytoin, and Primidone in Partial and Secondarily Generalized Tonic–Clonic SeizuresNew England Journal of Medicine, 1985